News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
489,200 Results
Type
Article (33561)
Company Profile (107)
Press Release (455532)
Multimedia
Podcasts (29)
Webinars (8)
Section
Business (134065)
Career Advice (786)
Deals (21876)
Drug Delivery (72)
Drug Development (58802)
Employer Resources (68)
FDA (14424)
Job Trends (10517)
News (234858)
Policy (23853)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2304)
Accelerated approval (4)
Adcomms (15)
Allergies (79)
Alliances (36263)
ALS (71)
Alzheimer's disease (1084)
Antibody-drug conjugate (ADC) (81)
Approvals (14456)
Artificial intelligence (213)
Autoimmune disease (19)
Automation (14)
Bankruptcy (179)
Best Places to Work (8649)
BIOSECURE Act (6)
Biosimilars (58)
Biotechnology (75)
Bladder cancer (56)
Brain cancer (24)
Breast cancer (222)
Cancer (1745)
Cardiovascular disease (134)
Career advice (676)
Career pathing (16)
CAR-T (104)
Cell therapy (284)
Cervical cancer (19)
Clinical research (48627)
Collaboration (607)
Compensation (196)
Complete response letters (14)
COVID-19 (1987)
CRISPR (31)
C-suite (170)
Cystic fibrosis (68)
Data (1736)
Decentralized trials (2)
Denatured (19)
Depression (33)
Diabetes (210)
Diagnostics (4820)
Digital health (14)
Diversity (5)
Diversity, equity & inclusion (18)
Drug discovery (82)
Drug pricing (71)
Drug shortages (22)
Duchenne muscular dystrophy (60)
Earnings (48697)
Editorial (23)
Employer branding (6)
Employer resources (63)
Events (68629)
Executive appointments (517)
FDA (15516)
Featured Employer (20)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (525)
Gene editing (80)
Generative AI (16)
Gene therapy (201)
GLP-1 (478)
Government (3608)
Grass and pollen (3)
Guidances (41)
Healthcare (15108)
Huntington's disease (12)
IgA nephropathy (21)
Immunology and inflammation (75)
Indications (21)
Infectious disease (2082)
Inflammatory bowel disease (95)
Inflation Reduction Act (7)
Influenza (33)
Intellectual property (60)
Interviews (87)
IPO (9480)
IRA (24)
Job creations (2208)
Job search strategy (606)
Kidney cancer (8)
Labor market (10)
Layoffs (225)
Leadership (7)
Legal (4611)
Liver cancer (59)
Lung cancer (272)
Lymphoma (122)
Machine learning (4)
Management (25)
Manufacturing (175)
MASH (49)
Medical device (13858)
Medtech (13861)
Mergers & acquisitions (12776)
Metabolic disorders (500)
Multiple sclerosis (71)
NASH (12)
Neurodegenerative disease (70)
Neuropsychiatric disorders (17)
Neuroscience (1498)
NextGen: Class of 2025 (5035)
Non-profit (3388)
Northern California (1698)
Now hiring (20)
Obesity (247)
Opinion (124)
Ovarian cancer (59)
Pain (76)
Pancreatic cancer (65)
Parkinson's disease (107)
Partnered (15)
Patents (153)
Patient recruitment (86)
Peanut (45)
People (41366)
Pharmaceutical (31)
Pharmacy benefit managers (16)
Phase I (14729)
Phase II (21225)
Phase III (16622)
Pipeline (841)
Policy (70)
Postmarket research (1879)
Preclinical (5562)
Press Release (33)
Prostate cancer (86)
Psychedelics (20)
Radiopharmaceuticals (178)
Rare diseases (262)
Real estate (3714)
Recruiting (27)
Regulatory (17325)
Reports (19)
Research institute (2055)
Resumes & cover letters (124)
Rett syndrome (4)
RNA editing (2)
RSV (27)
Schizophrenia (58)
Series A (90)
Series B (61)
Service/supplier (7)
Sickle cell disease (35)
Southern California (1491)
Special edition (5)
Spinal muscular atrophy (121)
Sponsored (24)
Startups (2652)
State (1)
Stomach cancer (12)
Supply chain (46)
Tariffs (11)
The Weekly (10)
United States (16085)
Vaccines (480)
Venture capitalists (21)
Weight loss (155)
Women's health (21)
Worklife (6)
Date
Today (112)
Last 7 days (422)
Last 30 days (1770)
Last 365 days (23889)
2025 (7102)
2024 (25575)
2023 (29346)
2022 (38964)
2021 (41856)
2020 (40987)
2019 (35742)
2018 (27191)
2017 (24038)
2016 (23176)
2015 (27190)
2014 (20516)
2013 (16950)
2012 (18481)
2011 (19009)
2010 (17201)
Location
Africa (484)
Alabama (28)
Alaska (4)
Arizona (181)
Arkansas (12)
Asia (29450)
Australia (4761)
California (3913)
Canada (1421)
China (393)
Colorado (189)
Connecticut (204)
Delaware (130)
Europe (62992)
Florida (686)
Georgia (158)
Idaho (43)
Illinois (406)
India (19)
Indiana (278)
Iowa (4)
Japan (131)
Kansas (81)
Kentucky (17)
Louisiana (9)
Maine (35)
Maryland (728)
Massachusetts (2900)
Michigan (158)
Minnesota (295)
Mississippi (2)
Missouri (74)
Montana (26)
Nebraska (21)
Nevada (39)
New Hampshire (61)
New Jersey (1286)
New Mexico (20)
New York (1207)
North Carolina (698)
North Dakota (5)
Northern California (1698)
Ohio (162)
Oklahoma (5)
Oregon (30)
Pennsylvania (974)
Puerto Rico (10)
Rhode Island (29)
South America (696)
South Carolina (22)
South Dakota (1)
Southern California (1491)
Tennessee (84)
Texas (674)
Utah (148)
Virginia (108)
Washington D.C. (44)
Washington State (364)
West Virginia (3)
Wisconsin (45)
489,200 Results for "mevion medical systems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mevion Delivers First-Ever FIT Compact Proton Therapy System to Stanford Health Care
January 21, 2025
·
3 min read
Press Releases
Mevion Medical Systems and NELCO Worldwide Partner to Accelerate Proton Therapy Adoption
September 11, 2024
·
3 min read
Press Releases
CORRECTING and REPLACING Mevion Delivers Wisconsin’s First Compact Proton Therapy System to the Froedtert & the Medical College of Wisconsin Clinical Cancer Center
November 12, 2024
·
4 min read
Press Releases
Mevion Delivers Wisconsin’s First Compact Proton Therapy System to MCW Cancer Center
November 12, 2024
·
3 min read
Genetown
Siteman Cancer Center Begins Treatment with Latest Mevion Proton Therapy System
Mevion Medical Systems announced today that the world’s first single-room proton therapy system has completed the upgrade to the latest MEVION S250i Proton Therapy System ® with FLASH* capabilities, and has begun treating patients in November at the S. Lee Kling Proton Therapy Center at Siteman Cancer Center.
November 16, 2023
·
3 min read
Business
Kansas City Proton Institute Begins Cancer Treatments with Advanced MEVION S250i Proton Therapy System
Kansas City Proton Institute (KCPI), the first physician-led proton therapy center in the Midwest, and Mevion Medical Systems announced today that the first four patients were treated at Kansas City Proton Institute on Dec. 19, with the MEVION S250i Proton Therapy System® .
December 22, 2023
·
5 min read
Genetown
Mevion Launches “Mevion Capital” to Provide Customized Proton Therapy Funding Solutions for Healthcare Communities in US and Canada
Mevion Medical Systems, the leading global provider of compact proton therapy systems for use in radiation treatment for cancer patients, announces the launch of ‘Mevion Capital’ in the US and Canada.
October 1, 2023
·
2 min read
RaySearch and Mevion - A synergy of innovation transforming proton therapy
RaySearch Laboratories AB is proud to announce the continued commitment with Mevion Medical Systems, the leading global provider of compact proton therapy solutions, to develop new proton therapy solutions in support of current and emerging technologies.
October 2, 2023
·
3 min read
Business
Mevion and RaySearch: A Synergy of Innovation Transforming Proton Therapy
Mevion Medical Systems, the leading global provider of compact proton therapy solutions, and RaySearch Laboratories AB, the market leader in software solutions for radiation oncology, are proud to announce their continued commitment to developing new proton therapy solutions.
October 2, 2023
·
5 min read
Genetown
Re-Imagine Proton Therapy: Mevion Breaks Down Barriers at ASTRO 2023
Mevion Medical Systems, the leading provider of compact single-room proton therapy systems, will showcase products and solutions to re-imagine proton therapy by breaking down access barriers at the upcoming American Society of Radiation Oncology 65th Annual Meeting.
September 28, 2023
·
4 min read
1 of 48,920
Next
